Details
Sickle cell disease stems from a single genetic mutation that changes the shape of red blood cells, blocking blood flow and damaging organs over time. Now, gene editing has delivered remarkable results against the disease. But with science no longer the obstacle, another challenge has arisen: How to deliver such precise treatment while ensuring it reaches everyone who could benefit from it.
Here's how experts hope to overcome this challenge: https://on.natgeo.com/Jbjp5N